Further development of the Helicobacter pylori mouse vaccination model

Vaccine

Volumn 18, Issue 24, 2000, Pages 2677-2685

  Sutton, Philip ^a   Wilson, John ^a   Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colony forming assay; Helicobacter pylori; Histology; Immunisation; Mouse model; Urease assay

Indexed keywords

BACTERIAL VACCINE; CHOLERA TOXIN; UREASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ASSAY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0034213549     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00052-9     Document Type: Article

References (31)

1. Megraud F. Antibiotic resistance in Helicobacter pylori infection. Br. Med. Bull. 54:1998;207-216.
2. Hoffman P.S., Goodwin A., Johnsen J., Magee K., Veldhuyzen van Zanten S.J.O. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori - repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J. Bacteriol. 178:1996;4822-4829.
3. Czinn S.J., Nedrud J.G. Oral immunization against Helicobacter pylori. Infect. Immun. 59:1991;2359-2363.
4. Lee A., Fox J.G., Otto G., Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterol. 99:1990;1315-1323.
5. Czinn S.J., Cai A., Nedrud J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine. 11:1993;637-642.
6. Michetti P., Corthesy-Theulaz I., Davin C., Haas R., Vaney A.C., Heitz M., et al. Immunisation of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterol. 107:1994;1002-1011.
7. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 267:1995;1655-1658.
8. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., Dixon M.F. A standardized mouse model of Helicobacter pylori infection - introducing the Sydney strain. Gastroenterol. 112:1997;1386-1397.
9. Doidge C., Gust I., Lee A., Buck F., Hazell S., Manne U. Therapeutic immunisation against Helicobacter infection. Lancet. 343:1994;914-915.
10. Corthesy Theulaz I., Porta N., Glauser M., Saraga E., Vaney A.C., Haas R., et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterol. 109:1995;115-121.
11. Ghiara P., Rossi M., Marchetti M., Ditommaso A., Vindigni C., Ciampolini F., et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun. 65:1997;4996-5002.
12. Radcliff F.J., Hazell S.L., Kolesnikow T., Doidge C., Lee A. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect. Immun. 65:1997;4668-4674.
13. Ferrero R.L., Thiberge J.M., Kansau I., Wuscher N., Huerre M., Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc. Nat. Acad. Sci. (USA). 92:1995;6499-6503.
14. Corthesy Theulaz I.E., Hopkins S., Bachmann D., Saldinger P.F., Porta N., Haas R., et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoP(c) expressing urease A and B subunits. Infect. Immun. 66:1998;581-586.
15. Gomezduarte O.G., Lucas B., Yan Z.X., Panthel K., Haas R., Meyer T.F. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated salmonella typhimurium producing urease subunits A and B. Vaccine. 16:1998;460-471.
16. Chen M.H., Lee A., Hazell S., Hu P.J., Li Y.Y. Immunisation against gastric infection with Helicobacter species - first step in the prophylaxis of gastric cancer? Zbl. Bakt. (Int. J. Med. Microbiol.). 280:1993;155-165.
17. Genta R.M., Robason G.O., Graham D.Y. Simultaneous visualization of Helicobacter pylori and gastric morphology - a new stain. Hum. Pathol. 25:1994;221-226.
18. Hazell S.L., Borody T.J., Gal A, Lee A. Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am. J. Gastroenterol. 82:1987;292-296.
19. Michetti P., Kreiss C., Kotloff K.L., Porta N., Blanco J.L., Bachmann D., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 116:1999;804-812.
20. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Expt. Med. 188:1998;2277-2788.
21. Bayerdorffer E., Lehn N., Hatz R., Mannes G.A., Obertel H., Sauerbruch T., et al. Differences in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology. 102:1992;1575-1582.
22. Cuenca R., Blanchard T.G., Czinn S.J., Nedrud J.G., Monath T.P., Lee C.K., et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 110:1996;1770-1775.
23. Mohammadi M., Czinn S., Redline R., Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:1996;4729-4738.
24. Ferrero R.L., Thiberge J.M., Labigne A. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology. 113:1997;185-194.
25. Fan X.J., Chua A., O'Connell M.A., Kelleher D., Keeling P.W.N. Interferon-gamma and tumor necrosis factor production in patients with Helicobacter pylori infection. IJMS. 162:1993;408-411.
26. Delios M.M., Manghetti M., Decarli M., Costa F., Baldari C.T., Burroni D., et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:1997;962-967.
27. Ernst P.B., Reves V.E., Gourley W.H., Haberle H., Bamford K.B. Is the Th1/Th2 lymphocyte balance upset by Helicobacter pylori infection? Hunt R.H., Tytgat G.N.J. Helicobacter pylori: Basic mechanisms to clinical cure. 1996;150-157 Kluwer Academic Publishers, Dordrecht.
28. Mohammadi M., Nedrud J., Redline R., Lycke N., Czinn S.J. Murine CD4 T-cell response to Helicobacter infection - TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology. 113:1997;1848-1857.
29. Constant S., Pfeiffer C., Woodard A., Pasqualini T., Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1995;1591-1596.
30. Hosken N.A., Shibuya K., Heath A.W., Murphy K.M., O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1995;1579-1584.
31. Constant S.L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.